Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study. [PDF]
Lerman BJ +17 more
europepmc +1 more source
Decoding Small Cell Lung Cancer: Molecular Subtypes, Surface Antigens, and the Target-Modality Problem. [PDF]
Zambrano Iglesias MI +6 more
europepmc +1 more source
Lurbinectedin in treating CNS metastases from small cell neuroendocrine prostate cancer-a case report. [PDF]
Gunuganti A +4 more
europepmc +1 more source
Characterization of Alternaria alternata alternariol monomethyl ether with a potential antiproliferative activity by topoisomerases inhibition; molecular docking and dynamic simulations. [PDF]
El-Sayed ASA +9 more
europepmc +1 more source
The Enemy of My Enemy: Two Cases of De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer with BRCA2 Alterations and Brain Metastases. [PDF]
Kjer MF +5 more
europepmc +1 more source
The Influence of TDP1 Inhibitor Usnic Acid Derivative OL9-116 on the Effects of Topotecan in Human Cells. [PDF]
Kornienko TE +13 more
europepmc +1 more source
Molecular targeted therapy in combination with chemotherapy for the treatment of platinum-resistant/refractory ovarian cancer (PROC): a systematic review and network meta-analysis. [PDF]
Ying T, E S, Ying H.
europepmc +1 more source
Treatment of leukemic ocular infiltrations with intraarterial chemotherapy in very early mixed relapse of B-cell acute lymphoblastic leukemia. [PDF]
Andrzejewska M +9 more
europepmc +1 more source
Targeting TROP2 and Exploiting AUNIP as a Determinant of ADC Cytotoxicity and Chemosensitivity in HNSCC and ESCA Cancers. [PDF]
Bai J +12 more
europepmc +1 more source
Topoisomerase inhibitors in cervical cancer: mechanistic insights and therapeutic strategies. [PDF]
Reddy Y +6 more
europepmc +1 more source

